← Insider buys

BCPC

Balchem Corporation · Basic Materials

Insiders sold $2.2M of Balchem Corporation in the last 12 months and bought none

$0Bought, 12 mo
$2.2MSold, 12 mo
$5.6BMarket cap

BCPC over the last year

No insider buys filed in this year

BCPC after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Congress

Members reported 3 trades in BCPC since 2025.

Every filing

41 insider filings since 2016, newest first

BCPCSell

David B Fischer · Director

$1.2M−50.0%Dec 5
BCPCSell

Gunsteren Job Leonard Van · SVP, GM, Specialty Products

$920K−39.0%Dec 5
BCPCSell

Gunsteren Job Leonard Van · SVP, GM, Specialty Products

$1.4M−48.0%Aug 2
BCPCSell

William A. Backus · VP and Chief Accounting Officer

$860K−48.0%Aug 1
BCPCSell

Michael Robert Sestrick · SVP and CTO

$298K−28.0%May 13
BCPCSell

David B Fischer · Director

$765K−36.0%May 10
BCPCSell

Michael Brent Tignor · SVP and CHRO

$841K−39.0%Mar 12
BCPCSell

Matthew David Wineinger · Director

$209K−18.0%Mar 6
BCPCSell

William A. Backus · VP and Chief Accounting Officer

$2.5M−73.0%Feb 27
BCPCSell

William A. Backus · VP and Chief Accounting Officer

$2.3M−54.0%Feb 23
BCPCSell

Michael Robert Sestrick · SVP and CTO

$1.7M−62.0%Feb 23
BCPCSell

Theodore L Harris · Chair, President and CEO

$9.9M−49.0%Feb 23
BCPCSell

David B Fischer · Director

$500K−22.0%Sep 12
BCPCSell

Michael Robert Sestrick · SVP and CTO

$300K−30.0%May 4
BCPCSell

David B Fischer · Director

$381K−15.0%Mar 22
BCPCSell

Gunsteren Job Leonard Van · VP

$131K−41.0%Aug 16
BCPCSell

Gunsteren Job Leonard Van · VP

$626K−78.0%Aug 5
BCPCSell

William A. Backus · Chief Accounting Officer

$3.0M−66.0%Aug 9
BCPCSell

Scott C Mason · VP

$309K−24.0%Nov 16
BCPCSell

David F Ludwig · VP, Specialty, In

$1.1M−40.0%Aug 30
BCPCBuy

Scott C Mason · VP

$254K+31.0%Aug 5
BCPCBuy

Daniel E Knutson · Director

$58K+77.0%Nov 14
BCPCSell

Edward Mcmillan · Director

$207K−9.0%Jun 15
BCPCSell

William A. Backus · CFO and Treasurer

$4.1M−74.0%Mar 13
BCPCSell

William A. Backus · CFO and Treasurer

$1.2M−45.0%Mar 3
BCPCSell

Dino A Rossi · Retired Director

$62K−3.0%Jan 6
BCPCSell

Edward Mcmillan · Director

$132K−5.0%Jan 4
BCPCSell

Dino A Rossi · Director

$1.4M−41.0%Dec 8
BCPCSell

Dino A Rossi · Director

$1.3M−49.0%Nov 16
BCPCSell

Dino A Rossi · Director

$1.3M−52.0%Oct 7
BCPCSell

Matthew David Houston · General Counsel and Secretary

$271K−17.0%Sep 21
BCPCSell

Dino A Rossi · Director

$1.1M−34.0%Sep 9
BCPCSell

Edward Mcmillan · Director

$105K−5.0%Sep 2
BCPCSell

William A. Backus · CFO and Treasurer

$824K−41.0%Aug 26
BCPCSell

Dino A Rossi · Director

$1.1M−26.0%Aug 11
BCPCSell

Dino A Rossi · Director

$1.0M−21.0%Jul 14
BCPCSell

Dino A Rossi · Director

$1.9M−29.0%Jun 20
BCPCSell

Edward Mcmillan · Director

$185K−9.0%Jun 20
BCPCSell

Matthew David Houston · General Counsel and Secretary

$313K−17.0%May 17
BCPCSell

Dino A Rossi · Director

$1.0M−11.0%Apr 21
BCPCSell

Dino A Rossi · Director

$979K−11.0%Mar 23
About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.